Postvaccination Mortality in the USA: unusual proportion of deaths in reports on vaccine reactions from January 2021
VAERS is the federal institution centralizing reports on adverse reactions to vaccines in the USA. Data are not extensive and are limited to those reported to VAERS. The data are publicly available since 1990 at:
Inspection of these data across various years find consistent patterns in percentages of postvaccination deaths according to age classes. For each year, there are tens of thousands of individual cases reported.
In January 2021 there were 2947 reported cases, an amount similar to monthly amounts reported in previous years. Among these, 1980 were post-COVID-19 Pfizer and 954 Moderna vaccination reactions.
In January 2021, 456 postvaccination deaths were reported, which is unusually high. In January 2020, VAERS reports only 14 postvaccination deaths, and 166 deaths for the whole year 2020.
Overall, percentages of deaths according to age classes for January 2021 resembles those observed for previous years. However, the main difference is in the systematically much higher percentages of deaths, up to 150 times higher for age class 60 to 69.
This suggests highly dangerous adverse effects by mRNA-based vaccine technology as compared to classical vaccines.
Figures summarizing the data along age classes are attached.
The vertical y-axis is the percentage of deaths among adverse postvaccination reports for each age class.
The horizontal x-axis are age classes, grouped each ten years, besides infants up to 2 years and children from 2 to 9.
Figure 1 compares mortalities vs reports percent in January 2021 with those across the whole year of 2021, presenting mortality percentages along a linear scale.
Figures 2-4 present the data along a logarithmic scale for the y axis, enabling a better inspection of the data.
Figures 3-4 include the January 2021 data and the following data:
Separate data for years 2016-2020 (Figure 3),
Separate data for 2020 and the average of years 2015-2019 (Figure 4).
These analyses of VAERS' biased sample of postvaccination adverse reports do not replace analyses of an unbiased sample of all vaccinated individuals, including postvaccination death cases unreported to VAERS. We got no answer yet for similar data from Israel, which were requested by one of us at the beginning of the 2nd week of February on the basis of the law for information freedom.
Hervé Seligmann – Haim Yativ